Effect of a novel enteral nutrition mixture with probiotics versus standard enteral nutrition on gastrointestinal complications in critically ill surgical patients: a single-center randomized controlled trial
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-Oct-2026 16:15 ET (31-Oct-2026 20:15 GMT/UTC)
A randomised controlled trial conducted in critically ill patients recovering from abdominal surgery found that a novel probiotic-enriched tube feeding formula reduced serious gut complications dramatically compared to standard enteral nutrition — with no cases of diarrhea recorded in the probiotic group, against a 60% rate in the control group — though the authors caution that the two formulas also differed in their nutritional composition, making it impossible to attribute the benefit to probiotics alone.
A Swansea University researcher whose work could help create more inclusive icons and symbols for neurodivergent people has been awarded a prestigious scholarship to present her findings at a leading international psychology conference.
EPFL researchers have developed a nanopore sensor that distinguishes seven toxins from cyanobacteria blooms, and can detect one common toxin at concentrations far below World Health Organization guidelines.
Glycomics, the comprehensive study of glycans and glycoconjugates, has emerged as a powerful tool for disease biomarker discovery. Changes in glycosylation patterns accompany many pathological processes, reflecting alterations in cellular metabolism and function. This review presents insights from cohort studies that have linked specific glycan signatures to disease risk, progression, and outcomes. We discuss the potential of glycomics for precision medicine and early disease detection. The integration of glycomics with other omics approaches promises to enhance our understanding of disease mechanisms and improve diagnostic capabilities.
Chronic kidney disease and end-stage renal disease (ESRD) represent significant global health burdens. Genetic factors contribute substantially to ESRD susceptibility, yet much of the heritability remains unexplained. This X chromosome-wide association study (XWAS) identified novel loci on the X chromosome associated with ESRD risk. Our findings expand the genetic architecture of kidney disease and may inform future therapeutic targets. The study highlights the importance of including the X chromosome in genetic association studies, as it harbors variants that may contribute to disease susceptibility.